Reata Pharmaceuticals Inc
F:2R3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Reata Pharmaceuticals Inc
F:2R3
|
US |
|
Freightways Group Ltd
ASX:FRW
|
NZ |
|
F
|
Forwardly Inc
OTC:FORW
|
US |
|
Columbia Financial Inc
NASDAQ:CLBK
|
US |
|
Xtera Communications Inc
OTC:XCOMQ
|
US |
|
M
|
Manila Broadcasting Co
XPHS:MBC
|
PH |
|
DUG Technology Ltd
ASX:DUG
|
AU |
|
Agatos SpA
MIL:AGA
|
IT |
|
S
|
Sparebank 1 Ostlandet
OSE:SPOL
|
NO |
|
Afya Ltd
NASDAQ:AFYA
|
BR |
|
Almonty Industries Inc
F:ALI0
|
CA |
|
A
|
Advanced Micro Devices Inc
SWB:AMD
|
US |
|
Countplus Ltd
ASX:CUP
|
AU |
|
Copperleaf Technologies Inc
TSX:CPLF
|
CA |
|
Soko Seiren Co Ltd
TSE:3578
|
JP |
|
Lark Distilling Co Ltd
ASX:LRK
|
AU |
|
NAHL Group PLC
LSE:NAH
|
UK |
|
Sparebanken Ost
OSE:SPOG
|
NO |
|
F
|
Farm 51 Group SA
WSE:F51
|
PL |
|
D
|
Digicap Co Ltd
KOSDAQ:197140
|
KR |
|
Power Finance Corporation Ltd
NSE:PFC
|
IN |
|
Capcom Co Ltd
OTC:CCOEF
|
JP |
|
Sanofi SA
OTC:SNYNF
|
FR |
|
Digitiliti Inc
OTC:DIGI
|
US |
Bankruptcy Probability
Reata Pharmaceuticals Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Reata Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
R
|
Reata Pharmaceuticals Inc
F:2R3
|
6.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Reata Pharmaceuticals Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Reata Pharmaceuticals Inc has total debt of 73.1m USD. This includes both short-term (0 USD) and long-term (73.1m USD) debt.
You can find a full breakdown on its Balance Sheet.
